ArticleMelanoma research2018
The BET-bromodomain inhibitor JQ1 mitigates vemurafenib drug resistance in melanoma.
Bei Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it
ArticleMelanoma research2018
Bei Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.